By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Medical professionals utilize the Riptide Aspiration System for endovascular and neurovascular operations. The mechanical thrombectomy it offers is a treatment for acute ischemic stroke that involves removing blood clots from brain blood arteries. A blood clot in the brain blocks a blood vessel during an acute ischemic stroke, depriving the affected area of oxygen and nutrients.
By employing specialized equipment to remove the clot, mechanical thrombectomy is a minimally invasive surgery that seeks to restore blood flow. The Riptide Aspiration System is a comprehensive gadget made up of various parts that are all perfectly engineered to function together. A catheter, a sheath, a guidewire, and an aspiration pump are some of these parts.
The system’s main part, the catheter, is utilized to reach the blocked blood vessel in the brain. It is inserted into the clot site after being guided by a guidewire through the arteries. The distal tip of the catheter can be inserted through the clot to engage and seize it.
As the catheter travels through the blood arteries, a protective sheath is placed over it. It aids the catheter’s movement within the vasculature by offering support and stability. The catheter is guided and maneuvered through the blood vessels using a tiny wire called a guidewire. The catheter is then advanced over the guidewire once it has been first introduced into the vascular.
An essential part of the Riptide Aspiration System is the aspiration pump. In order to aspirate the clot into a collection canister, it generates negative pressure or suction. This suction aids in removing the clot from the blood vessel blockage. The aspiration pump’s ability to deliver controlled, reliable suction makes it possible to effectively collect the clot.
When performing mechanical thrombectomy treatments, the Riptide Aspiration System has a number of benefits. Its sophisticated catheter design enables exact access and navigation to the clot site. The catheter’s distal tip is designed to successfully engage and capture the clot, making removal easier.
The controlled suction capabilities of the aspiration pump help to ensure the most effective clot retrieval, reducing the chance of clot fragmentation and embolization to other areas of the brain. The system’s parts are made to function well together, giving medical personnel a dependable and simple instrument to utilize while performing mechanical thrombectomy operations.
Improved patient outcomes in acute ischemic stroke have been linked to the use of the Riptide Aspiration System in mechanical thrombectomy. Rapid clot removal and blood flow restoration may limit brain injury, enhance neurological outcomes, and lessen disability.
It is crucial to remember that the Riptide Aspiration System should only be used by licensed healthcare professionals who are knowledgeable about how the device works and the particular surgery being carried out. For best results and to reduce dangers, patients must be carefully chosen, and set criteria and protocols must be followed.
In conclusion, the Riptide Aspiration System is an advanced medical tool used in mechanical thrombectomy treatments to remove blood clots from blocked blood arteries in the brain during acute ischemic stroke. Together, its parts—the catheter, sheath, guidewire, and aspiration pump—enable accurate navigation, clot engagement, and productive clot retrieval.
The Riptide Aspiration System is essential in the treatment of acute ischemic stroke because it quickly restores blood flow, potentially improving patient outcomes and lowering disability.
The Global Riptide Aspiration System Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Riptide Aspiration System for Acute Ischemic Stroke Receives FDA Approval. According to a statement from Medtronic, the manufacturer of the device, the FDA has approved the Riptide Aspiration System for thrombus retrieval via the Arc Catheter for revascularization in patients with acute ischemic stroke owing to intracranial large artery occlusive illness.
Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) therapy or who fail IV t-PA therapy are candidates for treatment, according to a Medtronic statement. The Penumbra System, Penumbra Pump MAX, and Riptide Aspiration System were contrasted in non-clinical animal testing.
The devices were judged to be equivalent in an FDA review. The FDA did not demand any additional testing before approval. The Solitaire Platinum Revascularization Device, made by Medtronic, is now joined by the Riptide Aspiration System. This device is indicated for thrombus removal for patients with acute ischemic stroke who have persisting proximal anterior circulation, massive vascular blockage, and smaller core infarcts.
Additionally, within eight hours of the onset of symptoms, the device is approved for eliminating thrombus from a significant cerebral vessel in patients with ischemic stroke.
The Reperfusion Catheter is inserted into the cerebral vasculature using a guide catheter or long femoral sheath, and it is then moved over a neurovascular guidewire to the primary occlusion location. To separate the thrombus and aspirate it from the occluded vessel, the Penumbra Reperfusion Catheter is used in parallel with the Penumbra Separator or Penumbra Separator 3D and an aspiration source.
The Penumbra Reperfusion Catheter releases the Penumbra Separator or Penumbra Separator 3D. At the proximal margin of the main blockage, the Penumbra Separator is cycled through the Penumbra Reperfusion Catheter. By cycling the Penumbra Reperfusion Catheter, the Penumbra Separator 3D is first deployed inside the thrombus and then resheathed.
This makes the thrombus easier to aspirate, debulk, and lessen or perhaps get rid of the endovascular clot burden.
